<unk>  <unk>  is a genetic disease characterized by myocyte loss and fibro-fatty tissue replacement of the<unk><unk>  myocardium. This puts patients into risk of life-threatening<unk>  arrhythmias and slowly progressive<unk>  dysfunction. The diagnostic is challenging. Diagnosis of<unk>  relays on a scoring system, with major or minor criteria on the Revised Task Force Criteria. Pharmacologic treatment of arrhythmias, catheter ablation of<unk>  tachycardia, and ICD are main goals of the treatment.
Arrhythmogenic right ventricular cardiomyopathy
Noncompaction cardiomyopathy thromboembolism
Aicardi syndrome
Tachycardia induced cardiomyopathy
Noncompaction cardiomyopathy
Hypertrophic cardiomyopathy
Alcoholic cardiomyopathy
Long QT syndrome